首页> 美国卫生研究院文献>Gland Surgery >Paradoxical roles for FOXA1 in anti-estrogen resistance and as a luminal differentiation factor in breast cancer

【2h】

Paradoxical roles for FOXA1 in anti-estrogen resistance and as a luminal differentiation factor in breast cancer

机译：FOXA1在抗雌激素耐药性和作为乳腺癌的管腔分化因子中的悖论作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Gland Surgery
作者
M.A. Christine Pratt;
展开▼
作者单位

展开▼
年(卷),期 2012(1),1
年度 2012
页码 9–11
总页数 3
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Deletion of Foxa1 in the mouse mammary gland results in abnormal accumulation of luminal progenitor cells: a link between reproductive factors and ER-/TNBC breast cancer? [J] . Sirinapa Sribenja, Orla Maguire, Kristopher Attwood, American Journal of Cancer Research . 2021,第6期

机译：在小鼠乳腺中缺失Foxa1导致腔祖细胞的异常积累：生殖因子与eR-/ TNBC乳腺癌之间的联系？
2. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes [J] . Jimin Guo, Lucie Canaff, Charles Vincent Rajadurai, Breast Cancer Research . 2014,第6期

机译：乳腺癌抗雌激素抗性3抑制转化生长因子β/ smad信号传导和伴有良好的乳腺癌疾病结果
3. Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 protein [J] . Ibrahim Rama, Lemoine Antoinette, Bertoglio Jacques, The international journal of biochemistry and cell biology . 2015,第Null期

机译：人类丝状增强剂1诱导的结直肠癌细胞迁移：丝氨酸磷酸化的作用以及与乳腺癌抗雌激素抵抗性3蛋白的相互作用
4. Characterization of endogenous phosphorylation in p130Cas, an anti-estrogen resistance generating protein in human breast cancer. [C] . Giuseppe Infusini, Anthony Makkinje, David H. Perlman, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：P130CAs中内源性磷酸化的表征，人乳腺癌中抗雌激素产生蛋白质。
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes [O] . Jimin Guo, Lucie Canaff, Charles Vincent Rajadurai, 2014

机译：乳腺癌抗雌激素耐药性3抑制转化生长因子β/ Smad信号传导并与良好的乳腺癌疾病结局相关
7. Studying GATA3, FOXA1, and ELF5 transcription factors in the evaluation of prognosis in luminal breast cancer patients [O] . S. V. Vtorushin, D. V. Vasilchenko, M. V. Zavyalova, 2021

机译：研究GATA3，FOXA1和ELF5转录因子在评估腔乳腺癌患者的预后
8. Breast Cancer Prevention by Hormonally Induced Mammary Gland Differentiation: The Role of a Novel Mammary Growth Inhibitor and Differentiation Factor MRG (Addendum) [R] . Shi, Y. E. 2003

机译：通过激素诱导的乳腺分化预防乳腺癌：新型乳腺生长抑制剂和分化因子mRG的作用（附录）

Paradoxical roles for FOXA1 in anti-estrogen resistance and as a luminal differentiation factor in breast cancer

著录项

相似文献

相关主题

期刊订阅